by Zahra Mahmoudjafari
Explore expert insights from ASTCT on building scalable, safe CGT (cell and gene therapy) programs, including key infrastructure, operational strategies, and sustainability considerations. This...
by Alex Kadhim
In a nationwide, retrospective cohort study, researchers from St. Mary’s Hospital, Kurume, and a nationwide consortium of Japanese transplant centers have shown that mycophenolate mofetil...
by Alex Kadhim
A recent single-center retrospective study, published in Transplantation and Cellular Therapy, investigated post-transplant outcomes in patients with TP53-mutated or 17p-deleted myeloid...
by Alex Kadhim
Researchers from the Hackensack University Medical Center have demonstrated that EZH2, a chromatin-modifying epigenetic enzyme, promotes alloreactive T cell survival during graft-versus-host...
by Alex Kadhim
In a single-center phase 2 study (CAR-PRISM; NCT05767359), researchers from the Dana Farber Cancer Institute have shown that a single infusion of BCMA-directed CAR T cell therapy with...
by Blood Advances
Toxicities related to axicabtagene ciloleucel (axi-cel) can be safely and effectively managed, suggest findings from a single-center study.